News
Ankit Aggarwal - Biotech Capital Markets In 2025: Discipline, Strategy, And A New Era Of Selectivity
Ankit Aggarwal is an Executive Director at J.P. Morgan in New York, where he leads capital markets and strategic advisory for ...
A new report from Pitchbook suggests we’re in for a period of more sustainable investing, with VC firms continuing to create ...
Jefferies has predicted more small tuck-in deals to come, as biotechs struggle to access capital despite key clinical ...
At the same time, biotechnology is opening new paths as an alternative to antibiotics. Countries such as Norway, Chile, and ...
The beauty industry is undergoing a significant transformation, driven by scientific advances, evolving consumer expectations ...
The integration of synthetic biology into environmental and resource management offers promising avenues for addressing sustainability challenges.
Discover how gene editing and lab-grown meat are revolutionising healthcare and food in 2025, offering personalised ...
Excerpted with permission from Our Future is Biotech: A Plain English Guide to How a Tech Revolution is Changing Our Lives ...
RevivBio, a trailblazing biotech company Redefining Biologics and Biosensors development, welcomes Dr. Ron Meeusen to its Board of Directors. Dr. Meeusen is a renowned leader in biotechnology, with a ...
BioMentorHub and One Health Incubator have officially launched the first Romanian bootcamp dedicated to early-stage biotech founders. Named 1Health Biotech Startup Bootcamp, the three-week program is ...
"Under Vision 2030, the Kingdom has emerged as a hub to innovate, invest and build the future breakthroughs that will ...
Ravi Narayan Venkatachalam, a U.S.-based biotechnologist at Jeneil Biotech, specializes in fermentation and specialty ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results